Dulanermin (Shanghai GeBaiDe)

度拉纳明（上海歌佰德生物技术）

Report date: 2022/01/14 13:23:58

Base Information

Drug NameDulanermin (Shanghai GeBaiDe)
Drug Alias NameApo2L肿瘤坏死因子相关凋亡诱导配体TRAlL重组人凋亡素2配体Tumor necrosis factor-related apoptosis-inducing ligand +[6] 
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionApoptosis stimulants
TargetsTumor necrosis factor receptor superfamily member 10BTumor necrosis factor receptor superfamily member 10A
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesShanghai Gebaide Biotechnology Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesShanghai Gebaide Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A